Special Edition 2021

Who are we? Prescrire is a French non-profit continuing education organisation, committed to better patient care Prescrire International is a monthly drug bulletin with selected texts translated from the French journal La Revue Prescrire

INTERNATIONAL

engl i sh.prescri re .org

President of Association Mieux Prescrire: Pierre Chirac, pharmacist ASSOCIATION MIEUX PRESCRIRE “To work, in all independence, in favour of quality healthcare, first and foremost in the interest of patients (...)” (Article 1 of the Association Mieux Prescrire bylaws). Prescrire International is published 11 times a year by Association Mieux Prescrire, a non-profit continuing education organisation (N° 11 711 075) under the French law of 1901. EDITORIAL STAFF Members of the Prescrire Editorial Staff sign a yearly declaration of absence of conflicts of interest, in accordance with Prescrire’s “Non merci...” Charter. Members are free from any interest contrary to Association Mieux Prescrire’s objectives (the Charter and the Declaration are available online at english.prescrire.org). Publishing reliable reviews that are easy to use and adapted to readers’ needs depends upon complex editorial procedures, all initiated and overseen by the members of Prescrire’s Editorial Staff. Members of the Editorial Staff define editorial goals.They oversee the literature search, the writing and rewriting of texts, and the review by a panel of outside experts (medical specialists, methodologists, representatives of Prescrire’s subscriber base…).They organise internal and external quality control procedures, and edit the final copy. Every draft is submitted, before publication, to a large number of external reviewers. Copyright Prescrire www.prescrire.org Registered address: 83, bd Voltaire 75011 Paris France Tel.: 33 01 49 23 72 80 E-mail: contact@prescrire.org Postal address: Prescrire - 83, bd Voltaire 75558 PARIS CEDEX 11 - FRANCE - Around 150 members of the Prescrire team - Around 100 external reviewers, experts in the subjects discussed and practising healthcare professionals For each issue, readers are provided with a list of the contributors to that issue. Around 250 people participate in the production and distribution of every issue of La Revue Prescrire , including:

patients – with the clear, comprehen- sive and reliable information they need about drugs and therapeutic and dia- gnostic strategies. Association Mieux Prescrire publishes a monthly journal in French, and an edition in English 11 times a year. A non-profit organisation, Prescrire is wholly financed by its subscribers, and accepts no advertising or other outside support. Reliable and relevant content Prescrire has the editorial and research capabilities necessary to ensure the accuracy of its reviews. Prescrire’s editors are healthcare professionals, specially trained in Prescrire’s editorial methods and free from conflicts of interest. Exacting quality-control procedures are applied to all editorial content.

The Association Mieux Prescrire (AMP), a non-profit organisation registered under the French law of 1901, manages all of Prescrire’s programmes and publ ications. The AMP is structured so as to be free of any influence from pharma- ceutical companies or healthcare institutions. Independent information Prescrire’ s purpose is stated in Article 1 of the AMP bylaws: “To work, in all independence, in favour of quality health- care, first and foremost in the interest of patients (...).” Prescrire offers continuing education and professional practice improvement programmes specifically adapted to the needs of healthcare professionals. Since 1981, Prescrire has provided healthcare professionals – and via them,

Subscribers can download any of the thousands of detailed reviews produced by Prescrire’s multidisciplinary team of healthcare professionals, and all including complete notes and references. All are available instantly , via an online table of contents going back to 1992, or via a search function.

SUBSCRIBE NOW FOR FULL ACCESS TO ONLINE CONTENT

Prescrire is a founder and member of ISDB, a network of drug bulletins that are independent of drug companies, which aims to promote international exchange of quality information on drugs and therapeutics. Website: www.isdbweb.org

Reliable, rigorously independent information on treatments and healthcare strategies, to enable fully informed decision-making. No grants, no advertising. No shareholders, no sponsors. Prescrire is funded by its subscribers.

Printed by Bulls Market Group/TPI